Skip to main content
Clinical Trials/ACTRN12616000679482
ACTRN12616000679482
Completed
Phase 2

Effect of 12-month daily resveratrol supplementation on brain health in post-menopausal women

niversity of Newcastle0 sites170 target enrollmentMay 25, 2016

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Menopause
Sponsor
niversity of Newcastle
Enrollment
170
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 25, 2016
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
niversity of Newcastle

Eligibility Criteria

Inclusion Criteria

  • Women aged 45\-85 years old. Post\-menopausal (cessation of menses for \> 12 months), with no change in medication type or dose for 3 months before the intervention.

Exclusion Criteria

  • Consuming HRT or seeking alternative therapy for the relief of postmenopausal symptoms (within the past three months).
  • Pregnant or breastfeeding.
  • Clinic BP \>160mmHg systolic or 100mmHg diastolic (determined at screening).
  • BMI\>40kg/m2 (determined at screening).
  • History of breast or cervical cancer, mastectomy or hysterectomy (not due to prolapse).
  • Smokers or currently on nicotine therapy.
  • Neurological conditions.
  • Kidney/liver disease.
  • Insulin therapy.
  • Warfarin therapy.

Outcomes

Primary Outcomes

Not specified

Similar Trials